Product Information
NEOMYCIN-POLYMYXIN-HC EAR SOLN is a generic product labeled by Sandoz Inc., priced at $4.0565 per ML under NDC 61314064610. Its NADAC has been published 575 times since Nov 28, 2013.
Strength
10; 3.5; 10000 mg/mL; mg/mL; [iU]/mL
Manufacturer
Sandoz Inc.NDC
61314064610
Classification
Generic
Dosage Form
SOLUTION
Route
AURICULAR (OTIC)
Last Updated
11/20/2024
Active Ingredients
HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA062423On Market Since
3/18/2003
Pharmacological Classes
Price Statistics
The NADAC for NEOMYCIN-POLYMYXIN-HC EAR SOLN has been published 575 times since Nov 28, 2013, and over the history we have for it it has risen 115.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.0565 per ML |
|---|---|
| All-time high | $6.5838 (Oct 13, 2021) |
| All-time low | $1.7627 (Sep 23, 2015) |
| Median price | $5.3611 |
| Average price | $4.8390 |
| Largest weekly change | +200.5% (Oct 21, 2015) |
| Weeks tracked | 575 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of NEOMYCIN-POLYMYXIN-HC EAR SOLN?
The current National Average Drug Acquisition Cost (NADAC) for NEOMYCIN-POLYMYXIN-HC EAR SOLN, manufactured by Sandoz Inc., is $4.0565 per ML (NDC 61314064610), effective Nov 27, 2024.
How has the price of NEOMYCIN-POLYMYXIN-HC EAR SOLN changed over time?
Over the history we have for it, the NADAC for NEOMYCIN-POLYMYXIN-HC EAR SOLN has risen 115.2%. It has been tracked across 575 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEOMYCIN-POLYMYXIN-HC EAR SOLN?
Since Nov 28, 2013, the NADAC for NEOMYCIN-POLYMYXIN-HC EAR SOLN has ranged from a low of $1.7627 (Sep 23, 2015) to a high of $6.5838 (Oct 13, 2021), with a median of $5.3611 per ML.
Are there cheaper alternatives to NEOMYCIN-POLYMYXIN-HC EAR SOLN?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, NEOMYCIN-POLYMYXIN-HC EAR SUSP, is $3.8269 per ML — about 6% below NEOMYCIN-POLYMYXIN-HC EAR SOLN.
Who manufactures NEOMYCIN-POLYMYXIN-HC EAR SOLN?
NEOMYCIN-POLYMYXIN-HC EAR SOLN (NDC 61314064610) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification